Alembic Pharmaceuticals gets FDA final approval for ulcerative colitis generic drug
Alembic Pharmaceuticals said that it has secured final approval for its abbreviated new drug application (ANDA) for Mesalamine Extended-Release Capsules USP, 0.375 g from the US Food & Drug Administration (FDA). The approved product is the generic of Apriso Extended-Release Capsules, 0.375 g, of Salix Pharmaceuticals. It is indicated for the maintenance of remission of […]